These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 9831174

  • 1. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M.
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [Abstract] [Full Text] [Related]

  • 2. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
    Scallon BJ, Trinh H, Nedelman M, Brennan FM, Feldmann M, Ghrayeb J.
    Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
    [Abstract] [Full Text] [Related]

  • 3. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M, Zimmermann G, Gottfried E, Chen CM, Grünwald U, Huang DC, Wu Lee YH, Dürkop H, Engelmann H, Scheurich P, Wajant H, Strasser A.
    EMBO J; 1999 Jun 01; 18(11):3034-43. PubMed ID: 10357816
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
    Amar S, Van Dyke TE, Eugster HP, Schultze N, Koebel P, Bluethmann H.
    J Inflamm; 1999 Jun 01; 47(4):180-9. PubMed ID: 9144075
    [Abstract] [Full Text] [Related]

  • 5. Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors.
    Rasmussen CA, Pace JL, Banerjee S, Phillips TA, Hunt JS.
    Placenta; 1999 Jun 01; 20(2-3):213-22. PubMed ID: 10195744
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F, Bourdon PR, Griffiths DA, Lawton P, Zafari M, Sizing ID, Miatkowski K, Ngam-ek A, Benjamin CD, Hession C, Ambrose CM, Meier W, Browning JL.
    J Immunol; 1997 Oct 01; 159(7):3299-310. PubMed ID: 9317128
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
    Frishman JI, Edwards CK, Sonnenberg MG, Kohno T, Cohen AM, Dinarello CA.
    J Infect Dis; 2000 Dec 01; 182(6):1722-30. PubMed ID: 11069245
    [Abstract] [Full Text] [Related]

  • 8. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling.
    Alexopoulou L, Pasparakis M, Kollias G.
    Eur J Immunol; 1997 Oct 01; 27(10):2588-92. PubMed ID: 9368614
    [Abstract] [Full Text] [Related]

  • 9. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors.
    Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, Tucker KK, Kohno T, Russell DA.
    Cytokine; 1995 Jan 01; 7(1):26-38. PubMed ID: 7749064
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U, Benhar I, Webber KO, Pastan I, Brinkmann U.
    Clin Cancer Res; 1996 Sep 01; 2(9):1523-31. PubMed ID: 9816329
    [Abstract] [Full Text] [Related]

  • 11. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W, Vandenabeele P, Fiers W.
    Cytokine; 1995 Oct 01; 7(7):701-9. PubMed ID: 8580379
    [Abstract] [Full Text] [Related]

  • 12. Differential roles of tumor necrosis factor-alpha and interferon-gamma in mouse hypermetabolic and anorectic responses induced by LPS.
    Arsenijevic D, Garcia I, Vesin C, Vesin D, Arsenijevic Y, Seydoux J, Girardier L, Ryffel B, Dulloo A, Richard D.
    Eur Cytokine Netw; 2000 Dec 01; 11(4):662-8. PubMed ID: 11125311
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K, Bienvenu J, Coiffier B, Salles G.
    Eur Cytokine Netw; 1995 Dec 01; 6(2):83-96. PubMed ID: 7578992
    [Abstract] [Full Text] [Related]

  • 14. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M, Medvedev AE, Sundan A, Espevik T.
    Cytokine; 1996 Jun 01; 8(6):430-8. PubMed ID: 8818539
    [Abstract] [Full Text] [Related]

  • 15. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
    Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL.
    Eur J Immunol; 1997 Aug 01; 27(8):2033-42. PubMed ID: 9295042
    [Abstract] [Full Text] [Related]

  • 16. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS, Majeau GR, Mackay F, Browning JL.
    J Inflamm; 1997 Aug 01; 46(4):220-34. PubMed ID: 8878796
    [Abstract] [Full Text] [Related]

  • 17. Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.
    Neve R, Kissonerghis M, Clark J, Feldmann M, Chernajovsky Y.
    Cytokine; 1996 May 01; 8(5):365-70. PubMed ID: 8726664
    [Abstract] [Full Text] [Related]

  • 18. Triggering of antitumor activity through melanoma-specific transduction of a constitutively active tumor necrosis factor (TNF) R1 chimeric receptor in the absence of TNF-alpha.
    Bazzoni F, Regalia E.
    Cancer Res; 2001 Feb 01; 61(3):1050-7. PubMed ID: 11221832
    [Abstract] [Full Text] [Related]

  • 19. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB.
    J Immunol; 1993 Aug 01; 151(3):1548-61. PubMed ID: 8393046
    [Abstract] [Full Text] [Related]

  • 20. TNF-alpha blockade by a dimeric TNF type I receptor molecule selectively inhibits adaptive immune responses.
    Colagiovanni DB, Suniga MA, Frazier JL, Edwards CK, Fleshner M, McCay JA, White KL, Shopp GM.
    Immunopharmacol Immunotoxicol; 2000 Nov 01; 22(4):627-51. PubMed ID: 11105778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.